IL1B and triple-negative breast carcinoma: On the other hand, zerumbone has been shown to prevent IL-1β-induced invasion of triple-negative breast cancer cells by inhibiting the expression of IL-8 and matrix metallopeptidase 3 (MMP3) [83].